Wednesday, February 17, 2010

Achillion Announces Positive 96-Week Data for Elvucitabine at the 17th Annual Conference on Retroviruses and Op.. http://bit.ly/9wHQSU
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)